iNKT cells kill CD1d+ tumor cells directly in a CD1d-dependent, Fas/FasL-mediated fashion and indirectly by stimulating NK and CD8 T cells via IFN-γ to attack tumors [85,92]. Here, CD8A is linked to neoplasm.